8-127416131-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001159542.3(POU5F1B):c.265G>A(p.Gly89Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000601 in 1,613,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001159542.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU5F1B | NM_001159542.3 | c.265G>A | p.Gly89Ser | missense_variant | 1/1 | ENST00000696633.1 | NP_001153014.1 | |
CASC8 | NR_117100.1 | n.1176+4698C>T | intron_variant, non_coding_transcript_variant | |||||
POU5F1B | NM_001395745.1 | c.265G>A | p.Gly89Ser | missense_variant | 2/2 | NP_001382674.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU5F1B | ENST00000696633.1 | c.265G>A | p.Gly89Ser | missense_variant | 1/1 | NM_001159542.3 | ENSP00000512769 | P1 | ||
CASC8 | ENST00000502082.5 | n.1176+4698C>T | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000117 AC: 29AN: 247508Hom.: 0 AF XY: 0.0000892 AC XY: 12AN XY: 134516
GnomAD4 exome AF: 0.0000602 AC: 88AN: 1461282Hom.: 0 Cov.: 114 AF XY: 0.0000674 AC XY: 49AN XY: 726936
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | The c.265G>A (p.G89S) alteration is located in exon 1 (coding exon 1) of the POU5F1B gene. This alteration results from a G to A substitution at nucleotide position 265, causing the glycine (G) at amino acid position 89 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at